This mechanism was entirely due to the interaction between the tumor cells and the TME: LATS1-2-null tumor cells induce type I IFN signaling by releasing nucleic acid–rich extracellular vesicles, thus facilitating CD8+ T cell expansion and tumor suppression [160]. This evidence concerns the gene CD8A and neoplasm.